staherb-Huperzine A Application

Huperzine-A

Huperzine-A-staherb

Item Name:Huperzine A extract powder

Test Method: HPLC

Specifications: Huperzine A 1% 5% 98% by HPLC

CAS No.: 120786-18-7

About Huperzine A:

Huperzine A has been proven superior to drugs licensed for the treatment of Alzheimer’s,including the leading anticholine sterase drugs physostigmine and tacrine. Huperzine A improved learning and memory in mice better than tacrine. Unlike physostigmine and tacrine, Huperzine A acts specifically on Ache in the brain rather than Ache found elsewhere in the body i.e., far less is wasted on irrelevat effects. Unlike physostigmine and tacrine, Huperzine A does notappear to bind to receptors in the central nervous system, which can cause adverse side efects. Itseffects last 10 to 12 times longer than physostigmine and tacrine (up to 8 hours).

About Huperzine A:

Huperzine A has been proven superior to drugs licensed for the treatment of Alzheimer’s,including the leading anticholine sterase drugs physostigmine and tacrine. Huperzine A improved learning and memory in mice better than tacrine. Unlike physostigmine and tacrine, Huperzine A acts specifically on Ache in the brain rather than Ache found elsewhere in the body i.e., far less is wasted on irrelevat effects. Unlike physostigmine and tacrine, Huperzine A does notappear to bind to receptors in the central nervous system, which can cause adverse side efects. Its effects last 10 to 12 times longer than physostigmine and tacrine (up to 8 hours).

发表评论

电子邮件地址不会被公开。 必填项已用*标注